From bench to bedside: Translating new research from genetics and neuroimaging into treatment development for early-onset schizophrenia

Early Intervention in Psychiatry

Volumn 3, Issue 4, 2009, Pages 243-258

  Kumra, Sanjiv ^a   Asarnow, Robert ^a   Grace, Anthony ^a   Keshavan, Matcheri ^a   McClellan, Jon ^a   Sikich, Linmarie ^a   Wagner, Ann ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Adolescents; Early onset schizophrenia; Intervention; Pathophysiology

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

BRAIN DEVELOPMENT; CHROMOSOME ABERRATION; CLINICAL RESEARCH; CLINICAL TRIAL; COGNITION; CYTOGENETICS; DIFFUSION TENSOR IMAGING; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG EFFICACY; ELECTROPHYSIOLOGY; ENVIRONMENTAL FACTOR; EPIGENETICS; EVOKED RESPONSE; GENETIC VARIABILITY; GENETICS; GRAY MATTER; HEREDITY; HUMAN; LONG TERM CARE; MENTAL HEALTH; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONSET AGE; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; WHITE MATTER;

AGE OF ONSET; BRAIN; EARLY MEDICAL INTERVENTION; HUMANS; NEUROIMAGING; SCHIZOPHRENIA; TRANSLATIONAL MEDICAL RESEARCH;

EID: 70849108188     PISSN: 17517885     EISSN: 17517893     Source Type: Journal    
DOI: 10.1111/j.1751-7893.2009.00142.x     Document Type: Review

References (151)

1. Cannon M, Caspi A, Moffitt TE. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry 2002, 59:449-56.
2. Fatemi SH, Folsom TD. The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull 2009, 35:528-48.
3. Asarnow JR, Tompson MC, McGrath EP. Annotation: childhood-onset schizophrenia: clinical and treatment issues. J Child Psychol Psychiatry 2004, 45:180-94.
4. Nicolson R, Rapoport JL. Childhood-onset schizophrenia: rare but worth studying. Biol Psychiatry 1999, 46:1418-28.
5. Rapoport JL, Addington AM, Frangou S, Psych MR. The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry 2005, 10:434-49.
6. Arango C, Moreno C, Martinez S. Longitudinal brain changes in early-onset psychosis. Schizophr Bull 2008, 34:341-53.
7. Kyriakopoulos M, Frangou S. Pathophysiology of early onset schizophrenia. Int Rev Psychiatry 2007, 19:315-24.
8. Benes FM, Turtle M, Khan Y, Farol P. Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Arch Gen Psychiatry 1994, 51:477-84.
9. Ashtari M, Cottone J, Ardekani BA. Disruption of white matter integrity in the inferior longitudinal fasciculus in adolescents with schizophrenia as revealed by fiber tractography. Arch Gen Psychiatry 2007, 64:1270-80.
10. Kendi M, Kendi AT, Lehericy S. Structural and diffusion tensor imaging of the fornix in childhood- and adolescent-onset schizophrenia. J Am Acad Child Adolesc Psychiatry 2008, 47:826-32.
11. Kumra S, Ashtari M, Cervellione KL. White matter abnormalities in early-onset schizophrenia: a voxel-based diffusion tensor imaging study. J Am Acad Child Adolesc Psychiatry 2005, 44:934-41.
12. Kumra S, Ashtari M, McMeniman M. Reduced frontal white matter integrity in early-onset schizophrenia: a preliminary study. Biol Psychiatry 2004, 55:1138-45.
13. Kyriakopoulos M, Vyas NS, Barker GJ, Chitnis XA, Frangou S. A diffusion tensor imaging study of white matter in early-onset schizophrenia. Biol Psychiatry 2008, 63:519-23.
14. Sowell ER, Toga AW, Asarnow R. Brain abnormalities observed in childhood-onset schizophrenia: a review of the structural magnetic resonance imaging literature. Ment Retard Dev Disabil Res Rev 2000, 6:180-5.
15. Janssen J, Reig S, Parellada M. Regional gray matter volume deficits in adolescents with first-episode psychosis. J Am Acad Child Adolesc Psychiatry 2008, 47:1311-20.
16. Bertolino A, Kumra S, Callicott JH. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging. Am J Psychiatry 1998, 155:1376-83.
17. Brooks WM, Hodde-Vargas J, Vargas LA, Yeo RA, Ford CC, Hendren RL. Frontal lobe of children with schizophrenia spectrum disorders: a proton magnetic resonance spectroscopic study. Biol Psychiatry 1998, 43:263-9.
18. O'Neill J, Levitt J, Caplan R. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia. Neuroimage 2004, 21(4):1781-9.
19. Stanley JA, Vemulapalli M, Nutche J. Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger onset age: a single-voxel 1H spectroscopy study. Schizophr Res 2007, 93(1-3):23-32.
20. Kumra S, Sporn A, Hommer DW. Smooth pursuit eye-tracking impairment in childhood-onset psychotic disorders. Am J Psychiatry 2001, 158:1291-8.
21. Ross RG, Olincy A, Harris JG. Evidence for bilineal inheritance of physiological indicators of risk in childhood-onset schizophrenia. Am J Med Genet 1999, 88:188-99.
22. Jacobsen LK, Giedd JN, Vaituzis AC. Temporal lobe morphology in childhood-onset schizophrenia. Am J Psychiatry 1996, 153:355-61.
23. Matsumoto H, Simmons A, Williams S, Pipe R, Murray R, Frangou S. Structural magnetic imaging of the hippocampus in early onset schizophrenia. Biol Psychiatry 2001, 49:824-31.
24. Nugent TF, Herman DH, Ordonez A. Dynamic mapping of hippocampal development in childhood onset schizophrenia. Schizophr Res 2007, 90:62-70.
25. Roofeh D, Cottone J, Burdick KE. Deficits in memory strategy use are related to verbal memory impairments in adolescents with schizophrenia-spectrum disorders. Schizophr Res 2006, 85(1-3):201-12.
26. Caplan R, Guthrie D, Shields WD, Mori L. Formal thought disorder in pediatric complex partial seizure disorder. J Child Psychol Psychiatry 1992, 33:1399-412.
27. White T, Kendi AT, Lehericy S. Disruption of hippocampal connectivity in children and adolescents with schizophrenia-a voxel-based diffusion tensor imaging study. Schizophr Res 2007, 90(1-3):302-7.
28. Pagsberg AK, Baare WF, Raabjerg Christensen AM. Structural brain abnormalities in early onset first-episode psychosis. J Neural Transm 2007, 114:489-98.
29. Douaud G, Smith S, Jenkinson M. Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. Brain 2007, 130(9):2375-86. Pt
30. Chang L, Friedman J, Ernst T, Zhong K, Tsopelas ND, Davis K. Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction. Biol Psychiatry 2007, 62:1396-404.
31. Thomas MA, Ke Y, Levitt J. Preliminary study of frontal lobe 1H MR spectroscopy in childhood-onset schizophrenia. J Magn Reson Imaging 1998, 8(4):841-6.
32. Strandburg RJ, Marsh JT, Brown WS. Continuous-processing related ERPS in adult schizophrenia: continuity with childhood onset schizophrenia. Biol Psychiatry 1999, 45:1356-69.
33. Strandburg RJ, Marsh JT, Brown WS, Asarnow RF, Higa J, Guthrie D. Continuous-processing related ERPS in schizophrenic and normal children. Biol Psychiatry 1994, 35:525-38.
34. Thaker GK. Neurophysiological endophenotypes across bipolar and schizophrenia psychosis. Schizophr Bull 2008, 34:760-73.
35. Hong LE, Tagamets M, Avila M, Wonodi I, Holcomb H, Thaker GK. Specific motion processing pathway deficit during eye tracking in schizophrenia: a performance-matched functional magnetic resonance imaging study. Biol Psychiatry 2005, 57:726-32.
36. Greenwood TA, Braff DL, Light GA. Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry 2007, 64:1242-50.
37. Hollis C. Child and adolescent (juvenile onset) schizophrenia. A case control study of premorbid developmental impairments. Br J Psychiatry 1995, 166:489-95.
38. Nicolson R, Lenane M, Singaracharlu S. Premorbid speech and language impairments in childhood-onset schizophrenia: association with risk factors. Am J Psychiatry 2000, 157:794-800.
39. Watkins JM, Asarnow RF, Tanguay PE. Symptom development in childhood onset schizophrenia. J Child Psychol Psychiatry 1988, 29:865-78.
40. Asarnow RF, Nuechterlein KH, Fogelson D. Schizophrenia and schizophrenia-spectrum personality disorders in the first-degree relatives of children with schizophrenia: the UCLA family study. Arch Gen Psychiatry 2001, 58:581-8.
41. Nicolson R, Brookner FB, Lenane M. Parental schizophrenia spectrum disorders in childhood-onset and adult-onset schizophrenia. Am J Psychiatry 2003, 160:490-5.
42. Werry JS, McClellan JM, Chard L. Childhood and adolescent schizophrenic, bipolar, and schizoaffective disorders: a clinical and outcome study. J Am Acad Child Adolesc Psychiatry 1991, 30:457-65.
43. Asarnow JR, Tompson MC, Goldstein MJ. Childhood-onset schizophrenia: a followup study. Schizophr Bull 1994, 20:599-617.
44. Asarnow JR. Childhood-onset schizotypal disorder: a follow-up study and comparison with childhood-onset schizophrenia. J Child Adolesc Psychopharmacol 2005, 15:395-402.
45. Fleischhaker C, Schulz E, Tepper K, Martin M, Hennighausen K, Remschmidt H. Long-term course of adolescent schizophrenia. Schizophr Bull 2005, 31(3):769-80.
46. Hollis C. Adult outcomes of child- and adolescent-onset schizophrenia: diagnostic stability and predictive validity. Am J Psychiatry 2000, 157:1652-9.
47. Remschmidt H, Theisen FM. Schizophrenia and related disorders in children and adolescents. J Neural Transm 2005, 69:121-41. Suppl
48. Rabinowitz J, Levine SZ, Hafner H. A population based elaboration of the role of age of onset on the course of schizophrenia. Schizophr Res 2006, 88:96-101.
49. Rhinewine JP, Lencz T, Thaden EP. Neurocognitive profile in adolescents with early-onset schizophrenia: clinical correlates. Biol Psychiatry 2005, 58:705-12.
50. Asarnow RF, Asamen J, Granholm E, Sherman T, Watkins JM, Williams ME. Cognitive/neuropsychological studies of children with a schizophrenia disorder. Schizophr Bull 1994, 20:647-69.
51. Thaden E, Rhinewine JP, Lencz T. Early-onset schizophrenia is associated with impaired adolescent development of attentional capacity using the identical pairs continuous performance test. Schizophr Res 2006, 81:157-66.
52. Asarnow RF, Sherman T. Studies of visual information processing in schizophrenic children. Child Dev 1984, 55(1):249-61.
53. Karatekin C, Asarnow RF. Components of visual search in childhood-onset schizophrenia and attention-deficit/hyperactivity disorder. J Abnorm Child Psychol 1998, 26:367-80.
54. Karatekin C, Asarnow RF. Working memory in childhood-onset schizophrenia and attention-deficit/hyperactivity disorder. Psychiatry Res 1998, 80:165-76.
55. Karatekin C, Asarnow RF. Exploratory eye movements to pictures in childhood-onset schizophrenia and attention-deficit/hyperactivity disorder (ADHD). J Abnorm Child Psychol 1999, 27(1):35-49.
56. Asarnow RF, Brown W, Strandburg R. Children with a schizophrenic disorder: neurobehavioral studies. Eur Arch Psychiatry Clin Neurosci 1995, 245(2):70-9.
57. Gochman PA, Greenstein D, Sporn A. IQ stabilization in childhood-onset schizophrenia. Schizophr Res 2005, 77:271-7.
58. Asarnow RF. Neurocognitive impairments in schizophrenia: a piece of the epigenetic puzzle. Eur Child Adolesc Psychiatry 1999, 8(1):I5-8. Suppl
59. Bilder RM, Goldman RS, Robinson D. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am J Psychiatry 2000, 157:549-59.
60. White T, Ho BC, Ward J, O'Leary D, Andreasen NC. Neuropsychological performance in first-episode adolescents with schizophrenia: a comparison with first-episode adults and adolescent control subjects. Biol Psychiatry 2006, 60:463-71.
61. Broome MR, Woolley JB, Tabraham P. What causes the onset of psychosis?. Schizophr Res 2005, 79(1):23-34.
62. Pantelis C, Yucel M, Wood SJ. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull 2005, 31(3):672-96.
63. Murray R. The Epidemiology of Schizophrenia 2003, Cambridge and New York, Cambridge University Press
64. Thaker GK, Carpenter WT. Advances in schizophrenia. Nat Med 2001, 7:667-71.
65. Addington AM, Gornick M, Sporn AL. Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified. Biol Psychiatry 2004, 55:976-80.
66. Addington AM, Gornick M, Duckworth J. GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Mol Psychiatry 2005, 10:581-8.
67. Addington AM, Gornick MC, Shaw P. Neuregulin 1 (8p12) and childhood-onset schizophrenia: susceptibility haplotypes for diagnosis and brain developmental trajectories. Mol Psychiatry 2007, 12:195-205.
68. Gornick MC, Addington AM, Sporn A. Dysbindin (DTNBP1, 6p22.3) is associated with childhood-onset psychosis and endophenotypes measured by the Premorbid Adjustment Scale (PAS). J Autism Dev Disord 2005, 35:831-8.
69. Sanders AR, Duan J, Levinson DF. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry 2008, 165:497-506.
70. Sullivan PF, Lin D, Tzeng JY. Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry 2008, 13:570-84.
71. McClellan JM, Susser E, King MC. Schizophrenia: a common disease caused by multiple rare alleles. Br J Psychiatry 2007, 190:194-9.
72. Walsh T, McClellan JM, McCarthy SE. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008, 320(5875):539-43.
73. Xu B, Roos JL, Levy S, van Rensburg EJ, Gogos JA, Karayiorgou M. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet 2008, 40:880-5.
74. Kumra S, Wiggs E, Krasnewich D. Brief report: association of sex chromosome anomalies with childhood-onset psychotic disorders. J Am Acad Child Adolesc Psychiatry 1998, 37:292-6.
75. Fish B. Neurobiologic antecedents of schizophrenia in children. Evidence for an inherited, congenital neurointegrative defect. Arch Gen Psychiatry 1977, 34:1297-313.
76. Ordonez AE, Bobb A, Greenstein D. Lack of evidence for elevated obstetric complications in childhood onset schizophrenia. Biol Psychiatry 2005, 58(1):10-15.
77. Stanfield AC, Moorhead TW, Harris JM, Owens DG, Lawrie SM, Johnstone EC. Increased right prefrontal cortical folding in adolescents at risk of schizophrenia for cognitive reasons. Biol Psychiatry 2008, 63:80-5.
78. Jacobsen LK, Giedd JN, Tanrikut C. Three-dimensional cortical morphometry of the planum temporale in childhood-onset schizophrenia. Am J Psychiatry 1997, 154:685-7.
79. Nopoulos PC, Giedd JN, Andreasen NC, Rapoport JL. Frequency and severity of enlarged cavum septi pellucidi in childhood-onset schizophrenia. Am J Psychiatry 1998, 155:1074-9.
80. Grossman AW, Churchill JD, McKinney BC, Kodish IM, Otte SL, Greenough WT. Experience effects on brain development: possible contributions to psychopathology. J Child Psychol Psychiatry 2003, 44(1):33-63.
81. Paus T, Keshavan M, Giedd JN. Why do many psychiatric disorders emerge during adolescence?. Nat Rev Neurosci 2008, 9:947-57.
82. Russell AT. The clinical presentation of childhood-onset schizophrenia. Schizophr Bull 1994, 20:631-46.
83. Pantelis C, Velakoulis D, McGorry PD. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003, 361(9354):281-8.
84. Sun D, Phillips L, Velakoulis D. Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr Res 2009, 108(1-3):85-92.
85. Hollis C. Developmental precursors of child- and adolescent-onset schizophrenia and affective psychoses: diagnostic specificity and continuity with symptom dimensions. Br J Psychiatry 2003, 182:37-44.
86. Grace AA. Disruption of cortical-limbic interaction as a substrate for comorbidity. Neurotox Res 2006, 10:93-101.
87. Rosenkranz JA, Grace AA. Cellular mechanisms of infralimbic and prelimbic prefrontal cortical inhibition and dopaminergic modulation of basolateral amygdala neurons in vivo. J Neurosci 2002, 22(1):324-37.
88. Gogtay N, Greenstein D, Lenane M. Cortical brain development in nonpsychotic siblings of patients with childhood-onset schizophrenia. Arch Gen Psychiatry 2007, 64:772-80.
89. Zabala A, Sanchez-Gonzalez J, Parellada M. Findings of proton magnetic resonance spectometry in the dorsolateral prefrontal cortex in adolescents with first episodes of psychosis. Psychiatry Res 2007, 156(1):33-42.
90. Addington J, Mansley C, Addington D. Weight gain in first-episode psychosis. Can J Psychiatry 2003, 48:272-6.
91. Homayoun H, Moghaddam B. Fine-tuning of awake prefrontal cortex neurons by clozapine: comparison with haloperidol and N-desmethylclozapine. Biol Psychiatry 2007, 61:679-87.
92. Sporn AL, Greenstein DK, Gogtay N. Progressive brain volume loss during adolescence in childhood-onset schizophrenia. Am J Psychiatry 2003, 160:2181-9.
93. Yurgelun-Todd DA, Killgore WD. Fear-related activity in the prefrontal cortex increases with age during adolescence: a preliminary fMRI study. Neurosci Lett 2006, 406:194-9.
94. Rosenkranz JA, Moore H, Grace AA. The prefrontal cortex regulates lateral amygdala neuronal plasticity and responses to previously conditioned stimuli. J Neurosci 2003, 23(35):11054-64.
95. Thompson JL, Pogue-Geile MF, Grace AA. Developmental pathology, dopamine, and stress: a model for the age of onset of schizophrenia symptoms. Schizophr Bull 2004, 30(4):875-900.
96. Berretta S, Benes FM. A rat model for neural circuitry abnormalities in schizophrenia. Nat Protoc 2006, 1(2):833-9.
97. Lodge DJ, Grace AA. Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia. J Neurosci 2007, 27(42):11424-30.
98. Medoff DR, Holcomb HH, Lahti AC, Tamminga CA. Probing the human hippocampus using rCBF: contrasts in schizophrenia. Hippocampus 2001, 11:543-50.
99. Weiss AP, Goff D, Schacter DL. Fronto-hippocampal function during temporal context monitoring in schizophrenia. Biol Psychiatry 2006, 60:1268-77.
100. Cunningham MG, Bhattacharyya S, Benes FM. Increasing interaction of amygdalar afferents with GABAergic interneurons between birth and adulthood. Cereb Cortex 2008, 18(7):1529-35.
101. Sirevaag AM, Greenough WT. Differential rearing effects on rat visual cortex synapses. III. Neuronal and glial nuclei, boutons, dendrites, and capillaries. Brain Res 1987, 424:320-32.
102. Reig S, Moreno C, Moreno D. Progression of brain volume changes in adolescent-onset psychosis. Schizophr Bull 2008, 35:233-43.
103. Thompson PM, Vidal C, Giedd JN. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci USA 2001, 98(20):11650-5.
104. Vidal CN, Rapoport JL, Hayashi KM. Dynamically spreading frontal and cingulate deficits mapped in adolescents with schizophrenia. Arch Gen Psychiatry 2006, 63(1):25-34.
105. James AC, James S, Smith DM, Javaloyes A. Cerebellar, prefrontal cortex, and thalamic volumes over two time points in adolescent-onset schizophrenia. Am J Psychiatry 2004, 161:1023-9.
106. Greenstein D, Lerch J, Shaw P. Childhood onset schizophrenia: cortical brain abnormalities as young adults. J Child Psychol Psychiatry 2006, 47:1003-12.
107. Bartzokis G, Nuechterlein KH, Lu PH, Gitlin M, Rogers S, Mintz J. Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study. Biol Psychiatry 2003, 53:412-21.
108. Hakak Y, Walker JR, Li C. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 2001, 98(8):4746-51.
109. Tkachev D, Mimmack ML, Ryan MM. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003, 362(9386):798-805.
110. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res 2004, 67:269-75.
111. Regenold WT, Phatak P, Marano CM, Gearhart L, Viens CH, Hisley KC. Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression. Psychiatry Res 2007, 151:179-88.
112. Ho BC, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry 2003, 60:585-94.
113. Dwork AJ, Mancevski B, Rosoklija G. White matter and cognitive function in schizophrenia. Int J Neuropsychopharmacol 2007, 10:513-36.
114. Kyriakopoulos M, Bargiotas T, Barker GJ, Frangou S. Diffusion tensor imaging in schizophrenia. Eur Psychiatry 2008, 23:255-73.
115. Harrison PJ, Law AJ. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatry 2006, 60:132-40.
116. Taveggia C, Thaker P, Petrylak A. Type III neuregulin-1 promotes oligodendrocyte myelination. Glia 2008, 56:284-93.
117. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?. J Psychiatr Res 1982, 17:319-34.
118. Keshavan MS, Anderson S, Pettegrew JW. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res 1994, 28:239-65.
119. Olney JW, Newcomer JW, Farber NB. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 1999, 33:523-33.
120. Lieberman JA, Tollefson GD, Charles C. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 2005, 62:361-70.
121. Konopaske GT, Dorph-Petersen KA, Pierri JN, Wu Q, Sampson AR, Lewis DA. Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacology 2007, 32(6):1216-23.
122. Pool D, Bloom W, Mielke DH, Roniger JJ, Gallant DM. A controlled evaluation of loxitane in seventy-five adolescent schizophrenic patients. Curr Ther Res Clin Exp 1976, 19:99-104.
123. Realmuto GM, Erickson WD, Yellin AM, Hopwood JH, Greenberg LM. Clinical comparison of thiothixene and thioridazine in schizophrenic adolescents. Am J Psychiatry 1984, 141:440-2.
124. Spencer EK, Kafantaris V, Padron-Gayol MV, Rosenberg CR, Campbell M. Haloperidol in schizophrenic children: early findings from a study in progress. Psychopharmacol Bull 1992, 28:183-6.
125. Kumra S, Frazier JA, Jacobsen LK. Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison. Arch Gen Psychiatry 1996, 53:1090-7.
126. Sikich L, Hamer RM, Bashford RA, Sheitman BB, Lieberman JA. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial. Neuropsychopharmacology 2004, 29:133-45.
127. Shaw P, Sporn A, Gogtay N. Childhood-onset schizophrenia: a double-blind, randomized clozapine-olanzapine comparison. Arch Gen Psychiatry 2006, 63:721-30.
128. Kumra S, Kranzler H, Gerbino-Rosen G. Clozapine and 'high-dose' olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison. Biol Psychiatry 2008, 63:524-9.
129. Kryzhanovskaya LA. Results from a double-blind placebo-controlled trial of olanzapine. 2006, In: 159th Annual Meeting of the APA. Toronto, Canada
130. Robb AS, Forbes RA, Marcus RN, Carson WH. Efficacy of aripiprazole in the treatment of adolescents with schizophrenia. 2007, In: Poster presentation at the 160th Annual Meeting of the American Psychiatric Association. San Diego, CA
131. Haas M, Unis A, Copenhaver M, Quiroz J, Kushner S, Kusumakar V. Efficacy and safety of risperidone in adolescents with schizophrenia. 2007, In: 160th Annual Meeting of the American Psychiatric Association; 2007; San Diego, CA
132. Sikich L, Frazier JA, McClellan J. Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study. Am J Psychiatry 2008, 165:1420-31.
133. Kumra S, Oberstar JV, Sikich L. Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia. Schizophr Bull 2008, 34:60-71.
134. McClellan J, Sikich L, Findling RL. Treatment of early-onset schizophrenia spectrum disorders (TEOSS): rationale, design, and methods. J Am Acad Child Adolesc Psychiatry 2007, 46:969-78.
135. Phillips LJ, McGorry PD, Garner B. Stress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders. Aust N Z J Psychiatry 2006, 40:725-41.
136. Floresco SB, Todd CL, Grace AA. Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons. J Neurosci 2001, 21(13):4915-22.
137. Floresco SB, West AR, Ash B, Moore H, Grace AA. Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat Neurosci 2003, 6:968-73.
138. Javitt DC, Jotkowitz A, Sircar R, Zukin SR. Non-competitive regulation of phencyclidine/sigma-receptors by the N-methyl-D-aspartate receptor antagonist D-(-)-2-amino-5-phosphonovaleric acid. Neurosci Lett 1987, 78:193-8.
139. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 1991, 148:1301-8.
140. Krystal JH, Karper LP, Seibyl JP. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994, 51:199-214.
141. Lewis DA, Moghaddam B. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch Neurol 2006, 63:1372-6.
142. Tan HY, Callicott JH, Weinberger DR. Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia. Cereb Cortex 2007, 17(1):i171-81. Suppl
143. Verma A, Moghaddam B. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J Neurosci 1996, 16(1):373-9.
144. Moghaddam B. Bringing order to the glutamate chaos in schizophrenia. Neuron 2003, 40:881-4.
145. Buchanan RW, Javitt DC, Marder SR. The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. Am J Psychiatry 2007, 164:1593-602.
146. Goff DC, Keefe R, Citrome L. Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials. J Clin Psychopharmacol 2007, 27:582-9.
147. Moghaddam B, Adams BW. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 1998, 281(5381):1349-52.
148. Patil ST, Zhang L, Martenyi F. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nat Med 2007, 13:1102-7.
149. Goel N, Bale TL. Examining the intersection of sex and stress in modeling neuropsychiatric disorders. J Neuroendocrinol 2009, 21:415-20.
150. Ueland T, Rund BR. Cognitive remediation for adolescents with early onset psychosis: a 1-year follow-up study. Acta Psychiatr Scand 2005, 111:193-201.
151. Wykes T, Newton E, Landau S, Rice C, Thompson N, Frangou S. Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophr Res 2007, 3(1):221-30.